Whittle H C, Davidson N M, Greenwood B M, Warrell D A, Tomkins A, Tugwell P, Zalin A, Bryceson A D, Parry E H, Brueton M, Duggan M, Rajković A D
Br Med J. 1973 Aug 18;3(5876):379-81. doi: 10.1136/bmj.3.5876.379.
In a controlled trial chloramphenicol proved as effective and much cheaper than penicillin for the treatment of group A meningococcal meningitis in Zaria, Nigeria. A short course of five days cured most patients. Adults and older children were soon able to take chloramphenicol by mouth, which reduced the cost and simplified treatment.It is suggested that chloramphenicol is a suitable alternative to sulphonamides for the treatment of meningococcal meningitis in those parts of Africa where the organism is sulphonamide-resistant.
在一项对照试验中,氯霉素被证明在尼日利亚扎里亚治疗A群脑膜炎球菌性脑膜炎时与青霉素一样有效,且成本低得多。五天的短疗程治愈了大多数患者。成人和大龄儿童很快就能口服氯霉素,这降低了成本并简化了治疗。有人建议,在非洲那些该病菌对磺胺类药物耐药的地区,氯霉素是治疗脑膜炎球菌性脑膜炎的磺胺类药物的合适替代物。